126 related articles for article (PubMed ID: 10962253)
21. Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States.
Yokoyama C; Mawatari A; Kawasaki A; Takeda C; Onoe K; Doi H; Newman-Tancredi A; Zimmer L; Onoe H
Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608810
[TBL] [Abstract][Full Text] [Related]
22. Serotonin type-1A receptor imaging in depression.
Drevets WC; Frank E; Price JC; Kupfer DJ; Greer PJ; Mathis C
Nucl Med Biol; 2000 Jul; 27(5):499-507. PubMed ID: 10962258
[TBL] [Abstract][Full Text] [Related]
23. Radioligands for the study of brain 5-HT(1A) receptors in vivo--development of some new analogues of way.
Pike VW; Halldin C; Wikström H; Marchais S; McCarron JA; Sandell J; Nowicki B; Swahn CG; Osman S; Hume SP; Constantinou M; Andrée B; Farde L
Nucl Med Biol; 2000 Jul; 27(5):449-55. PubMed ID: 10962249
[TBL] [Abstract][Full Text] [Related]
24. The pyridinyl-6 position of WAY-100635 as a site for radiofluorination--effect on 5-HT1A receptor radioligand behavior in vivo.
McCarron JA; Pike VW; Halldin C; Sandell J; Sóvágó J; Gulyas B; Cselényi Z; Wikström HV; Marchais-Oberwinkler S; Nowicki B; Dollé F; Farde L
Mol Imaging Biol; 2004; 6(1):17-26. PubMed ID: 15018825
[TBL] [Abstract][Full Text] [Related]
25. PET evaluation of [(18)F]FCWAY, an analog of the 5-HT(1A) receptor antagonist, WAY-100635.
Carson RE; Lang L; Watabe H; Der MG; Adams HR; Jagoda E; Herscovitch P; Eckelman WC
Nucl Med Biol; 2000 Jul; 27(5):493-7. PubMed ID: 10962257
[TBL] [Abstract][Full Text] [Related]
26. Quantifying drug-related 5-HT1A receptor occupancy with.
Passchier J; van Waarde A; Pieterman RM; Willemsen AT; Vaalburg W
Psychopharmacology (Berl); 2001 May; 155(2):193-7. PubMed ID: 11401009
[TBL] [Abstract][Full Text] [Related]
27. Displacement of the PET ligand 18F-MPPF by the electrically evoked serotonin release in the rat hippocampus.
Rbah L; Leviel V; Zimmer L
Synapse; 2003 Sep; 49(4):239-45. PubMed ID: 12827643
[TBL] [Abstract][Full Text] [Related]
28. Cyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies.
Laćan G; Plenevaux A; Rubins DJ; Way BM; Defraiteur C; Lemaire C; Aerts J; Luxen A; Cherry SR; Melega WP
Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2256-66. PubMed ID: 18604533
[TBL] [Abstract][Full Text] [Related]
29. Drug action at the 5-HT(1A) receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-(11)C]WAY-100635.
Rabiner EA; Gunn RN; Wilkins MR; Sargent PA; Mocaer E; Sedman E; Cowen PJ; Grasby PM
Nucl Med Biol; 2000 Jul; 27(5):509-13. PubMed ID: 10962259
[TBL] [Abstract][Full Text] [Related]
30. Correlation between low/high affinity ratios for 5-HT(1A) receptors and intrinsic activity.
Assié MB; Cosi C; Koek W
Eur J Pharmacol; 1999 Dec; 386(1):97-103. PubMed ID: 10611469
[TBL] [Abstract][Full Text] [Related]
31. Imaging the 5-HT(1A) receptors with PET: WAY-100635 and analogues.
Houle S; DaSilva JN; Wilson AA
Nucl Med Biol; 2000 Jul; 27(5):463-6. PubMed ID: 10962251
[TBL] [Abstract][Full Text] [Related]
32. 5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: a[11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humans.
Rabiner EA; Wilkins MR; Turkheimer F; Gunn RN; Udo de Haes J; de Vries M; Grasby PM
J Pharmacol Exp Ther; 2002 Jun; 301(3):1144-50. PubMed ID: 12023549
[TBL] [Abstract][Full Text] [Related]
33. Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man.
Farde L; Ito H; Swahn CG; Pike VW; Halldin C
J Nucl Med; 1998 Nov; 39(11):1965-71. PubMed ID: 9829590
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Farde L; Ginovart N; Luthra SK; Gunn RN; Bench CJ; Sargent PA; Grasby PM
Nucl Med Biol; 1998 Apr; 25(3):215-23. PubMed ID: 9620626
[TBL] [Abstract][Full Text] [Related]
35. Characterization of 4-(2-hydroxyphenyl)-1-[2'-[N-(2''-pyridinyl)-p-fluorobenzamido]ethyl]piperazine (p-DMPPF) as a new potent 5-HT1A antagonist.
Defraiteur C; Plenevaux A; Scuvée-Moreau J; Rouchet N; Goblet D; Luxen A; Seutin V
Br J Pharmacol; 2007 Nov; 152(6):952-8. PubMed ID: 17704821
[TBL] [Abstract][Full Text] [Related]
36. Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar.
la Fougère C; Böning G; Bartmann H; Wängler B; Nowak S; Just T; Wagner E; Winter P; Rominger A; Förster S; Gildehaus FJ; Rosa-Neto P; Minuzzi L; Bartenstein P; Potschka H; Cumming P
Neuroimage; 2010 Jan; 49(2):1406-15. PubMed ID: 19796699
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Pardo L; Schaper K
J Med Chem; 2001 Jan; 44(2):198-207. PubMed ID: 11170629
[TBL] [Abstract][Full Text] [Related]
38. P-[18F]-MPPF: a potential radioligand for PET studies of 5-HT1A receptors in humans.
Shiue CY; Shiue GG; Mozley PD; Kung MP; Zhuang ZP; Kim HJ; Kung HF
Synapse; 1997 Feb; 25(2):147-54. PubMed ID: 9021895
[TBL] [Abstract][Full Text] [Related]
39. Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers.
Sibon I; Benkelfat C; Gravel P; Aznavour N; Costes N; Mzengeza S; Booij L; Baker G; Soucy JP; Zimmer L; Descarries L
Biol Psychiatry; 2008 Jun; 63(12):1135-40. PubMed ID: 18191817
[TBL] [Abstract][Full Text] [Related]
40. Pindolol occupancy of 5-HT(1A) receptors measured in vivo using small animal positron emission tomography with carbon-11 labeled WAY 100635.
Hirani E; Opacka-Juffry J; Gunn R; Khan I; Sharp T; Hume S
Synapse; 2000 Jun; 36(4):330-41. PubMed ID: 10819911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
